Takeda Pharmaceutical Files 6-K Report
Ticker: TKPHF · Form: 6-K · Filed: Jul 31, 2025 · CIK: 1395064
| Field | Detail |
|---|---|
| Company | Takeda Pharmaceutical Co Ltd (TKPHF) |
| Form Type | 6-K |
| Filed Date | Jul 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, administrative
TL;DR
Takeda filed a 6-K on 7/31/25, standard foreign issuer report.
AI Summary
Takeda Pharmaceutical Company Limited filed a Form 6-K on July 31, 2025, reporting as a foreign private issuer. The filing indicates Takeda's principal executive offices are located at 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan. Takeda is required to file annual reports under Form 20-F.
Why It Matters
This filing provides routine updates on Takeda's status as a foreign private issuer and its reporting obligations with the SEC.
Risk Assessment
Risk Level: low — This is a routine administrative filing for a foreign private issuer and does not contain new financial or operational information.
Key Players & Entities
- Takeda Pharmaceutical Company Limited (company) — Filer
- 001-38757 (company) — SEC File Number
- 20-F (company) — Annual Report Form
- 6-K (company) — Report Form
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, used to furnish information which the registrant may be required to disclose or permitted to disclose to any stock exchange on which its securities are traded.
When was this Form 6-K filed?
This Form 6-K was filed on July 31, 2025.
What is Takeda Pharmaceutical Company Limited's SEC file number?
Takeda Pharmaceutical Company Limited's SEC file number is 001-38757.
Where are Takeda's principal executive offices located?
Takeda's principal executive offices are located at 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, 103-8668, Japan.
Does Takeda file its annual reports under Form 20-F or 40-F?
Takeda indicates it files its annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 31, 2025 regarding TAKEDA PHARMACEUTICAL CO LTD (TKPHF).